8-K
filed November 9, 2022, 6:59 PM ET
ticker SSKN
CIK 0001051514
earnings
confidence high
sentiment positive
materiality 0.65
STRATA Q3 2022 revenue $9.4M (+22% YoY); net loss widens; launches TheraClear X
STRATA Skin Sciences, Inc.
2022-Q3 EPS reported
-$0.16
revenue$25,559,000
- Revenue $9.4M vs $7.7M YoY (+22%); equipment revenue $3.6M (+80%); international sales $3.3M (+82%).
- Net loss $1.0M ($0.03/sh) vs $0.5M loss ($0.02/sh) in Q3 2021; non-GAAP adjusted EBITDA $1.1M up from $0.9M.
- Gross margin 61.6% (GAAP) vs 69.7% YoY; non-GAAP gross margin 67.0% vs 71.6%, impacted by amortization and product mix.
- U.S. commercial launch of TheraClear X acne therapy system targeting a $5.5B acne treatment market.
- Reiterates FY2022 revenue guidance of $33M–$35M, expects strong double-digit year-over-year growth.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
STRATA Skin Sciences, Inc. reported full-year 2022 results: revenue $33 million to $35 million. Guidance reaffirmed.
- Period
- full-year 2022
- Revenue
- $33 million to $35 million
- Guidance
- reaffirmed
- Result
- guidance update
Exact text from the filing
The company reiterated its full-year 2022 revenue guidance in the range of $33 million to $35 million.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
STRATA Skin Sciences, Inc. reported third quarter ended September 30, 2022 results: net income $1.0 million, EPS $0.03. Guidance reaffirmed.
- Period
- third quarter ended September 30, 2022
- Net income
- $1.0 million
- EPS
- $0.03
- Guidance
- reaffirmed
- Result
- reported results
Exact text from the filing
STRATA Skin Sciences Reports Strong Third Quarter 2022 Financial Results ● Strong revenue in the third quarter 2022 of $9.4 million , a 22% increase over the third quarter of 2021
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
STRATA Skin Sciences, Inc. reported third quarter ended September 30, 2022 results: net income $1.0 million, EPS $0.03. Guidance reaffirmed.
- Period
- third quarter ended September 30, 2022
- Net income
- $1.0 million
- EPS
- $0.03
- Guidance
- reaffirmed
- Result
- reported results
Exact text from the filing
Revenues for the third quarter of 2022 were $9.4 million, as compared to revenues of $7.7 million for the third quarter of 2021.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
STRATA Skin Sciences, Inc. reported third quarter ended September 30, 2022 results: net income $1.0 million, EPS $0.03. Guidance reaffirmed.
- Period
- third quarter ended September 30, 2022
- Net income
- $1.0 million
- EPS
- $0.03
- Guidance
- reaffirmed
- Result
- reported results
Exact text from the filing
Net loss for third quarter 2022 was $1.0 million, or a loss of $0.03 per basic and diluted common share, as compared to the net loss for the third quarter of 2021 of $0.5 million, or net loss of $0.02 per basic and diluted common share.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.